| Not Yet Recruiting | SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease NCT03867487 | Justin Ryder | Phase 2 |
| Not Yet Recruiting | Human Models of Selective Insulin Resistance: Pancreatic Clamp NCT06558422 | Columbia University | Phase 1 |
| Not Yet Recruiting | Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fat NCT07497750 | University Hospital, Toulouse | N/A |
| Recruiting | Effect of Insulin Lowering on Lipogenesis NCT07403604 | Columbia University | Phase 1 |
| Not Yet Recruiting | A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects. NCT07407634 | Xi'an Xintong Pharmaceutical Research Co.,Ltd. | EARLY_Phase 1 |
| Recruiting | A Study of Efimosfermin Alfa in Adults With Hepatic Impairment NCT07358546 | GlaxoSmithKline | Phase 1 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Adminis NCT07335198 | GlaxoSmithKline | Phase 1 |
| Withdrawn | FCI Effectiveness in NAFLD Stratification NCT05827432 | NHS Grampian | N/A |
| Recruiting | A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants Wit NCT07221188 | GlaxoSmithKline | Phase 3 |
| Not Yet Recruiting | Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED NCT06944353 | Northwestern University | N/A |
| Not Yet Recruiting | Liver Steatosis in Pediatric CD Patients NCT06206616 | University of Palermo | — |
| Recruiting | A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stag NCT07221227 | GlaxoSmithKline | Phase 3 |
| Recruiting | Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease NCT07294963 | Khyber Medical University Peshawar | N/A |
| Active Not Recruiting | JiGenerations Health Cohort Study：Parental Exposure and Intergenerational Health in China NCT07514377 | National Research Institute for Family Planning, China | — |
| Completed | FibroScan-Reproducibility and Repeatability Study NCT06877026 | Echosens | N/A |
| Recruiting | Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial NCT06138821 | Pichamol Jirapinyo, MD, MPH | N/A |
| Recruiting | Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise NCT07130318 | Cairo University | N/A |
| Recruiting | Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease NCT06355310 | Justin Ryder | Phase 2 |
| Recruiting | Cardiovascular Risk in Children With Chronic Conditions Study NCT07086989 | Semmelweis University | — |
| Not Yet Recruiting | Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequenc NCT06908122 | Assiut University | — |
| Active Not Recruiting | Mechanisms of Macrophage Polarization in HIRI in Patients With NAFLD NCT06950710 | Zhifeng Gao | — |
| Recruiting | Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patie NCT06863376 | Tanta University | Phase 2 |
| Enrolling By Invitation | Relationship Between Eating Patterns, Body Composition and the Detection of Fatty Liver in Children and Adoles NCT06888570 | IMDEA Food | — |
| Recruiting | Identification of Liver Fibrosis Biomarkers NCT06819917 | Roche Diagnostics GmbH | — |
| Not Yet Recruiting | Treatment and Handling Severe Obesity-Related Comorbidities in Adolescents Through Exercise NCT06520800 | University of Lisbon | N/A |
| Recruiting | The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older Adults NCT06717828 | Fujian Provincial Hospital | N/A |
| Not Yet Recruiting | MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin NCT06373523 | Post Graduate Institute of Medical Education and Research, Chandigarh | EARLY_Phase 1 |
| Recruiting | Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal NCT06707129 | Beijing Municipal Administration of Hospitals | — |
| Recruiting | Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM) NCT06571474 | Bettina Mittendorfer | — |
| Recruiting | Pyramidal Versus Continuous Training Effects on Fatty Liver NCT06803108 | Cairo University | N/A |
| Completed | Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MAS NCT06482112 | Merck Sharp & Dohme LLC | Phase 2 |
| Active Not Recruiting | A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017) NCT06465186 | Merck Sharp & Dohme LLC | Phase 2 |
| Recruiting | Fibrosis Lessens After Metabolic Surgery NCT06374875 | Ali Aminian | Phase 4 |
| Recruiting | Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome NCT06519162 | Chungnam National University Hospital | — |
| Recruiting | Study on the Correlation Between Fat Soluble Vitamins and Non-alcoholic Fatty Liver Disease NCT06512701 | First Affiliated Hospital of Zhejiang University | — |
| Withdrawn | Dexamethasone/Pancreatic Clamp P&F NCT06126354 | Columbia University | Phase 1 |
| Not Yet Recruiting | Aronia and Non-alcoholic Fatty Liver Disease NCT06450769 | Istanbul Kent University | N/A |
| Completed | Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using Fibroscan NCT07027332 | Bezmialem Vakif University | — |
| Recruiting | Human Models of Selective Insulin Resistance: Alpelisib, Part I NCT06354088 | Columbia University | Phase 1 |
| Active Not Recruiting | The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease NCT06113003 | Vanderbilt University Medical Center | EARLY_Phase 1 |
| Completed | EndoNAFLD: Relationship Between Fatty Liver Disease and Cardiovascular Diseases NCT06392828 | IMDEA Food | — |
| Unknown | Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome NCT06256289 | Ping Li,MD | Phase 4 |
| Completed | Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Dia NCT07269197 | Josip Juraj Strossmayer University of Osijek | — |
| Recruiting | Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study NCT06211868 | National University Hospital, Singapore | — |
| Unknown | Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease NCT06218342 | Sir Run Run Shaw Hospital | Phase 4 |
| Unknown | Efficacy Evaluation of Chang Geng Healthy Drink on Patients With Non-alcoholic Fatty Liver Disease NCT06266559 | Chang Gung Memorial Hospital | N/A |
| Completed | Ultrasound and Attenuation Imaging NCT06552377 | Hywel Dda Health Board | — |
| Unknown | Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Non-Alcoholic Fat NCT06225713 | The First Affiliated Hospital with Nanjing Medical University | N/A |
| Not Yet Recruiting | Direct Versus Indirect Effect of Amino Acids on Hepatokines NCT06240039 | University of Copenhagen | N/A |
| Recruiting | Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants NCT06704321 | Valbiotis | N/A |
| Completed | Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH NCT06104319 | GlaxoSmithKline | Phase 2 |
| Recruiting | Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD) NCT06133101 | Marialena Mouzaki | Phase 2 |
| Recruiting | The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes NCT06144593 | Hvidovre University Hospital | N/A |
| Recruiting | Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatt NCT06735118 | Yunnan Cancer Hospital | N/A |
| Unknown | The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: NCT06167902 | Peking Union Medical College Hospital | N/A |
| Recruiting | Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals NCT05890365 | Steno Diabetes Center Copenhagen | — |
| Recruiting | Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver Disease NCT04720560 | Assiut University | — |
| Withdrawn | Assessment of Fatty Liver With Thermo-acoustic Device NCT04302051 | Medical College of Wisconsin | — |
| Unknown | Transient Elastograghy to Detect Non Alcoholic Fatty Liver Disease in Renal Transplantation Recipients. NCT05894993 | Amany Khaled Ali Ahmed | — |
| Unknown | Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver NCT06501326 | Affiliated Hospital of Nantong University | Phase 4 |
| Unknown | Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER Study NCT06101758 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | N/A |
| Unknown | Calisthenics Versus High Intensity Interval Training in NAFL NCT06032650 | Cairo University | N/A |
| Completed | The Effect of GLP-1 Analogues on Liver Steatosis and Fibrosis in Diabetic and Obese Patients in a Clinical Set NCT07021443 | Universitair Ziekenhuis Brussel | — |
| Recruiting | Effect of Timed-Restricted Eating on Metabolic Health NCT06061042 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | N/A |
| Unknown | Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory NCT05751720 | Dr Adnan Agha | Phase 1 / Phase 2 |
| Unknown | Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD NCT05942963 | Jinnah Postgraduate Medical Centre | Phase 4 |
| Enrolling By Invitation | Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Effi NCT06152991 | Yoon Jun Kim | Phase 3 |
| Active Not Recruiting | Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis NCT05979779 | Rivus Pharmaceuticals, Inc. | Phase 2 |
| Unknown | The Clock Thickens: Morning or Evening Training for the Treatment of NAFLD? NCT05987748 | Leiden University Medical Center | N/A |
| Recruiting | Comorbidities Resolution After MGB Surgery and Change in Body Composition NCT06015620 | All India Institute of Medical Sciences, Bhubaneswar | — |
| Active Not Recruiting | Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement Study NCT06011356 | Imperial College London | — |
| Completed | Pancreatic Clamp in NAFLD NCT05724134 | Columbia University | Phase 1 |
| Completed | Comparison of Effectiveness of Obeticholic Acid With Vitamin E in Patients of Non-alcoholic Fatty Liver Diseas NCT07104786 | King Edward Medical University | Phase 2 |
| Completed | A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and NCT05970640 | Boehringer Ingelheim | Phase 1 |
| Terminated | A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD) NCT06007651 | Eli Lilly and Company | Phase 1 |
| Completed | Glycemic Effect of Diazoxide in NAFLD NCT05729282 | Columbia University | Phase 1 |
| Enrolling By Invitation | Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention. NCT05956379 | National Taiwan University Hospital | N/A |
| Unknown | Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM NCT06005012 | University of California, San Diego | Phase 2 |
| Completed | Pharmacoeconomic Evaluation of the Cost/effectiveness Ratio of Physical Exercise on Non-alcoholic Fatty Liver NCT06026293 | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | — |
| Active Not Recruiting | Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associ NCT05067621 | Yale University | Phase 2 |
| Recruiting | Smartphone App for Non-alcoholic Fatty Liver Disease NCT05180760 | The University of Hong Kong | N/A |
| Unknown | Omics Techniques in Fatty Liver Disease NCT05907408 | Universidade Federal do Rio de Janeiro | — |
| Completed | A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6 NCT05877547 | Merck Sharp & Dohme LLC | Phase 2 |
| Unknown | Diet, Immunometabolism and Non-alcoholic Fatty Liver Disease NCT05968378 | University College Dublin | N/A |
| Completed | Effects of Time-restricted Hypocaloric Diet in Patients with NAFLD NCT05866744 | Agricultural University of Athens | N/A |
| Completed | Effect of a Multi-ingredient on Visceral Adiposity and Non-alcoholic Fatty Liver Disease in Individuals With A NCT05807204 | Fundació Eurecat | N/A |
| Recruiting | Ambulatory Liver Fat Monitoring in Patients With Non-alcoholic Fatty Liver Disease NCT05754385 | The University of Hong Kong | N/A |
| Recruiting | InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer NCT05463796 | Dana-Farber Cancer Institute | — |
| Unknown | The Effect of Coenzyme Q10 on Endothelial, Vascular and Myocardial Function NCT05941910 | Attikon Hospital | Phase 2 |
| Recruiting | Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis NCT05821010 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 2 |
| Recruiting | Optimal Exercise Frequency to Reduce Liver Fat in Centrally Obese Adults With Non-Alcoholic Fatty Liver Diseas NCT05741957 | The University of Hong Kong | N/A |
| Completed | A Clinical Study to Evaluate the Effect of SIM01 in Female With NAFLD NCT05885373 | GenieBiome Limited | N/A |
| Recruiting | Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy i NCT05870969 | Ruijin Hospital | — |
| Unknown | Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Di NCT05779644 | RenJi Hospital | N/A |
| Completed | A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese Men NCT05742919 | Novo Nordisk A/S | Phase 1 |
| Completed | Semaglutide in Nonalcoholic Fatty Liver Disease NCT05813249 | Zagazig University | Phase 4 |
| Completed | Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study) NCT05804422 | Bogomolets National Medical University | N/A |
| Unknown | Investigation on Safety and Efficacy of Soybean Fermented Extract (MBS217) in Treating Patients With NAFLD NCT05686174 | National Taiwan University Hospital | Phase 1 |
| Completed | Effects of Time-restricted Eating Supported by Mobile Technology in Patients With Non-alcoholic Fatty Liver Di NCT05579158 | Hanyang University | N/A |
| Completed | Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD NCT05897606 | Sulaimani Polytechnic University | Phase 1 |
| Withdrawn | Effects of Mindfulness Based Stress Reduction Intervention in Patients With Non-alcoholic Fatty Liver Disease NCT05130346 | Virginia Commonwealth University | N/A |
| Unknown | CT Liver Fat Fraction Quantification NCT05676177 | Sheba Medical Center | N/A |
| Active Not Recruiting | Multi-morbidity Screening in People With Type 2 Diabetes and Pre Diabetes NCT06053177 | University of Liverpool | — |
| Unknown | Effect of Indian Hepatoprotective Diet in Reversibility of NAFLD NCT05696808 | Institute of Liver and Biliary Sciences, India | N/A |
| Active Not Recruiting | Phase 2b Study of GSK4532990 in Adults With NASH NCT05583344 | GlaxoSmithKline | Phase 2 |
| Unknown | Quantitative Detection Efficiency of UDFF for Nonalcoholic Fatty Liver Disease NCT05802199 | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | — |
| Unknown | Beneficial Effects of Dietary and Lifestyle Change in Overweight and Obese Subjects NCT05447351 | University of Bari | — |
| Completed | Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver Disease NCT06097039 | Zagazig University | — |
| Unknown | Comparison of Hepatus and FibroScan for Evaluation of Fibrosis and Steatosis NCT05786963 | Beijing Friendship Hospital | — |
| Recruiting | CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome NCT05623150 | Institut National de la Santé Et de la Recherche Médicale, France | — |
| Unknown | Porphyromonas Gingivalis and Severity of Fibrosis in Patients With Non-alcoholic Fatty Liver Disease NCT05654129 | University Hospital, Toulouse | N/A |
| Withdrawn | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAR 502 in Healthy Subjects NCT05203367 | BAR Pharmaceuticals s.r.l. | Phase 1 |
| Recruiting | Effects of VLCKD in Metabolic Syndrome NCT05275608 | Azienda Ospedaliero Universitaria Maggiore della Carita | N/A |
| Recruiting | Quantifying Hepatic Mitochondrial Fluxes in Humans NCT05305287 | The University of Texas Health Science Center at San Antonio | Phase 4 |
| Unknown | Effectiveness of Inactive Vitamin D Supplementation in Non-Alcoholic Fatty Liver Disease Patients NCT05613192 | Ain Shams University | Phase 3 |
| Completed | Lifestyle Guidance Methods in NAFLD NCT05792488 | Ziekenhuis Oost-Limburg | N/A |
| Completed | High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease NCT05578404 | Tanta University | Phase 2 |
| Completed | A Clinical Trial to Evaluate the Efficacy and Safety of MXP22 on Liver Health NCT05808049 | Vedic Lifesciences Pvt. Ltd. | N/A |
| Unknown | SRMA of the Effect of Soy Milk vs Cow's Milk on Cardiometabolic Outcomes NCT05637866 | University of Toronto | — |
| Completed | The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study NCT05712603 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — |
| Unknown | Clinical Epidemiology of NAFLD in Children and Adolescents NCT05526274 | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | — |
| Active Not Recruiting | Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH NCT05462353 | Gannex Pharma Co., Ltd. | Phase 2 |
| Completed | Treating Pediatric NAFLD with Nutrition NCT05499585 | University of California, San Diego | N/A |
| Enrolling By Invitation | The Effect of Bariatric Surgery on Hepatic Metabolism in Non-Alcoholic Fatty Liver Disease NCT05551559 | Helsinki University Central Hospital | N/A |
| Recruiting | Soluble Fibre Supplementation in NAFLD NCT05480696 | McMaster University | Phase 2 |
| Unknown | Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH NCT05120557 | E-Scopics | N/A |
| Active Not Recruiting | MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia NCT05464784 | MediciNova | Phase 2 |
| Completed | Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Live NCT05560607 | AstraZeneca | Phase 1 |
| Unknown | Omics-based Predictors of NAFLD/Potential NASH NCT05301231 | National Research Centre, Egypt | — |
| Completed | Ultrasound Liver Fat Quantification on Pediatric Patients NCT06095479 | Philips (China) Investment CO., LTD | N/A |
| Unknown | Evaluation of Lipid Profile in Different Grades of Non-alcoholic Fatty Liver Disease Diagnosed by Ultrasound NCT05486429 | Sohag University | — |
| Completed | To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota Modulation NCT05402449 | GenMont Biotech Incorporation | N/A |
| Active Not Recruiting | Ursodeoxycholic Acid in Patients With NAFLD - Clinical Observation NCT05256979 | General University Hospital, Prague | — |
| Completed | A Digital Solution for Individuals With Non Alcoholic Fatty Liver Disease NCT05426382 | Sidekick Health | N/A |
| Unknown | A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D a NCT03970031 | Cirius Therapeutics, Inc. | Phase 3 |
| Recruiting | Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD NCT05766449 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | — |
| Completed | Motivational Interviewing in the Management of Non Alcoholic Fatty Liver Disease NCT06348628 | Madunil Anuk Niriella | N/A |
| Completed | Healthy Liver - Healthy Brain NCT05216796 | University of Texas at Austin | N/A |
| Completed | Pilot of Lifestyle Behavior Intervention for Non-Alcoholic Fatty Liver Disease NCT05200585 | The University of Texas Health Science Center, Houston | N/A |
| Completed | To Explore the Effectiveness of Jing-Si Herbal Tea Against Non-alcoholic Fatty Liver Disease NCT05858138 | Taichung Tzu Chi Hospital | N/A |
| Unknown | Fecal Microbiota Transplantation for the Treatment of Non-Alcoholic Steatohepatitis NCT03803540 | Puerta de Hierro University Hospital | Phase 1 |
| Recruiting | Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents NCT05268042 | University of Alabama at Birmingham | N/A |
| Unknown | Liver Fat Content and Bariatric Surgery NCT06064240 | yu li，MD | — |
| Recruiting | Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease NCT05332613 | Weill Medical College of Cornell University | N/A |
| Completed | Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression NCT05291104 | Fu Jen Catholic University Hospital | N/A |
| Recruiting | BeijngFH Health Cohort Study NCT05546086 | Beijing Friendship Hospital | — |
| Completed | Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH NCT05357248 | Better Therapeutics | N/A |
| Active Not Recruiting | Prevention of NAFLD in Hispanic Children NCT05292352 | Emory University | N/A |
| Completed | Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD) NCT05292911 | Altimmune, Inc. | Phase 1 |
| Unknown | UDFF Performance Evaluation ((Ultrason Derived Fat Fraction) NCT06080386 | University Hospital, Angers | — |
| Unknown | Assocaiton Between Uric Acid Trajecteries and Remission of NAFLD in NAFLD Individuals NCT05245890 | Ningbo No. 1 Hospital | — |
| Completed | Lysosomal Acid Lipase Activity in Nonalcoholic Fatty Liver Disease NCT05419765 | University of Roma La Sapienza | — |
| Completed | Effect of Adjustable Intragastric Balloon in Obese Non-alcoholic Fatty Liver Disease NCT04182646 | Asian Institute of Gastroenterology, India | N/A |
| Completed | Identification and Characterization of NAFLD in Turkey NCT05194553 | Maastricht University | — |
| Completed | Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver Disease NCT05209100 | AdventHealth Translational Research Institute | — |
| Recruiting | Intermittent Fasting for NAFLD in Adults NCT04899102 | Massachusetts General Hospital | N/A |
| Unknown | Impact Of Choline in Patients With NAFLD NCT05200156 | Ain Shams University | N/A |
| Completed | Intermittent Fasting Versus Diet to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic Fatty Liver Pa NCT06666894 | Cairo University | N/A |
| Completed | Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients NCT05474560 | Ain Shams University | Phase 4 |
| Completed | Electrical Impedance Tomography in Fatty Liver Detection NCT05189990 | The University of Hong Kong | — |
| Unknown | Serum Adiponectin as an Early Marker for Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease. NCT05106049 | Assiut University | — |
| Unknown | A Clinical Trial of XZP-6019 Tablets in Healthy Subjects NCT05063968 | Xuanzhu Biopharmaceutical Co., Ltd. | Phase 1 |
| Unknown | Impact of Cold Exposure on Metabolic Regulation in Children With Non Alcoholic Fatty Liver Disease (NAFLD) NCT04969744 | Guy's and St Thomas' NHS Foundation Trust | N/A |
| Completed | Non-Alcoholic Fatty Liver Disease and Anthropometric Measurements NCT05810506 | Bandırma Onyedi Eylül University | — |
| Completed | ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAF NCT05006885 | Altimmune, Inc. | Phase 1 |
| Recruiting | Prevention of NAFLD and CVD Through Lifestyle Intervention NCT05618626 | Pontificia Universidad Catolica de Chile | N/A |
| Completed | Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic NCT06244550 | Taipei City Hospital | N/A |
| Completed | Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation NCT04782050 | E-Scopics | N/A |
| Unknown | Prevalence of Metabolic Liver Diseases in Patients With Type 1 Diabetes Mellitus NCT05054712 | Consorci Sanitari de l'Alt Penedès i Garraf | — |
| Completed | Ectopic Fat in Singaporean Women - the Culprit Leading to Gestational Diabetes, Metabolic Syndrome, and Type 2 NCT05259475 | Institute for Human Development and Potential (IHDP), Singapore | N/A |
| Completed | Study to Investigate the Effect of L. Lactis CKDB001 Administration on Liver Aminotransferases in Subjects Wit NCT07378280 | Chuncheon Sacred Heart Hospital | N/A |
| Completed | Effect of Indo-Mediterranean Diet on Hepatic Steatosis and Fibrosis in NAFLD Children NCT05073588 | Institute of Liver and Biliary Sciences, India | N/A |
| Unknown | Effect of F. Prausnitzii on Glycemic Control NCT04938843 | MetaboGen AB | N/A |
| Unknown | MLCT Oil for Fatty Liver - PASS Trial NCT05217745 | National University Hospital, Singapore | N/A |
| Completed | Impact of FMT on the Phenome in Patients With NAFLD and Fibrosis NCT06024681 | Imperial College London | N/A |
| Active Not Recruiting | A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatt NCT04951219 | Madrigal Pharmaceuticals, Inc. | Phase 3 |
| Recruiting | Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease NCT05728697 | Brigham and Women's Hospital | — |
| Completed | Development and Evaluation of a Glucagon Sensitivity Test in Individuals With and Without Hepatic Steatosis NCT04907721 | University of Copenhagen | N/A |
| Completed | Single Ascending Dose of AMG 609 in Participants With Non-alcoholic Fatty Liver Disease NCT04857606 | Amgen | Phase 1 |
| Completed | Effects of Aerobic Exercise on Lean Non-alcoholic Fatty Liver Disease (NAFLD) NCT04882644 | The First Affiliated Hospital with Nanjing Medical University | N/A |
| Completed | Study in Healthy Adults Evaluating PF-07202954 NCT04857437 | Pfizer | Phase 1 |
| Recruiting | NAFLD Primary Care NCT04918732 | Maastricht University | N/A |
| Completed | Effect of L-Citrulline Supplementation on NAFLD in Adolescents With Obesity NCT04871360 | Universidad de Guanajuato | N/A |
| Completed | "CAP" Fetge Gras. Lifestyle Modification Program in Catalonia. NCT04988633 | Hospital Clinic of Barcelona | N/A |
| Unknown | Effect of Fatty Liver Disease on Bone Density NCT04850547 | Sohag University | — |
| Recruiting | AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL) NCT04807868 | AdventHealth Translational Research Institute | — |
| Completed | Effects of High-Intensity Interval Training Exercise in Adolescents With Hepatosteatosis NCT04342390 | Arkansas Children's Hospital Research Institute | N/A |
| Unknown | Plant Stanols and Liver Inflammation in Overweight and Obese Children NCT04783116 | Maastricht University Medical Center | N/A |
| Completed | Dairy Protien Rich Diet for NAFLD Patients NCT04841915 | University of Aarhus | N/A |
| Completed | Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study NCT04800094 | Philips Clinical & Medical Affairs Global | N/A |
| Completed | Economic Burden of NAFLD NCT05035043 | Hasselt University | N/A |
| Completed | Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases NCT04475276 | All India Institute of Medical Sciences, Bhubaneswar | Phase 4 |
| Completed | Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistan NCT04216589 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid Turnover NCT04859322 | Malte Palm Suppli, MD | N/A |
| Completed | Early Vascular Ageing in the YOUth NCT04598685 | VASCage GmbH | — |
| Completed | Characterization and Technical Evaluation of cT1 for NASH (CATE-NASH) NCT04341246 | Perspectum | — |
| Recruiting | "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors NCT04690972 | Institut National de la Santé Et de la Recherche Médicale, France | — |
| Completed | Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD. NCT04579874 | Fibronostics USA, Inc | N/A |
| Completed | Effect of Empagliflozin on Liver Fat in Non-diabetic Patients NCT04642261 | The University of Hong Kong | Phase 4 |
| Active Not Recruiting | Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver Disease NCT06623539 | Yokohama City University | Phase 2 |
| Unknown | Exercise and Cerebral Hemodynamics in MAFLD. NCT05520697 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | N/A |
| Completed | Influence of the Diversity and Composition of the Microbiota in the Development of Pediatric Fatty Liver NCT04575506 | Universidad Pública de Navarra | N/A |
| Completed | Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in Huma NCT04130321 | Laval University | N/A |
| Completed | Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study NCT04657523 | Philips Clinical & Medical Affairs Global | N/A |
| Completed | Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology. NCT04435054 | Hospices Civils de Lyon | N/A |
| Active Not Recruiting | Screening for NAFLD in Flanders NCT04647409 | Hasselt University | N/A |
| Recruiting | Integrated Diagnostics for Early Diagnosis of Liver Disease NCT04666402 | Manchester University NHS Foundation Trust | — |
| Unknown | Effects of Fecal Microbiota Transplantation on Weight in Obese Patients With Non-alcoholic Fatty Liver Disease NCT04594954 | Institute of Liver and Biliary Sciences, India | N/A |
| Unknown | Micro RNA Levels in NAFLD NCT04574557 | Assiut University | — |
| Completed | Tocotrienol as a Treatment for Non-alcoholic Fatty Liver Disease NCT06596382 | National University of Malaysia | N/A |
| Recruiting | The Olmsted NAFLD Epidemiology Study (TONES) NCT04365855 | Mayo Clinic | N/A |
| Unknown | Multicenter Registry of Nonalcoholic Fatty Liver Disease NCT04540731 | Hospital Italiano de Buenos Aires | — |
| Completed | Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH NCT04555434 | Chuncheon Sacred Heart Hospital | Phase 1 / Phase 2 |
| Completed | Role of Probiotics in Treatment of Pediatric NAFLD Patients by Assessing With Fibroscan NCT04671186 | Northwell Health | N/A |
| Completed | The Role of Immune Semaphorins in NAFLD NCT04573543 | University Hospital for Infectious Diseases, Croatia | — |
| Completed | The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects NCT04422496 | Sunshine Lake Pharma Co., Ltd. | Phase 1 |
| Completed | Multi-Parametric MRI Assessment of the Liver in the Dallas-FortWorth Metroplex Population NCT04336618 | Perspectum | — |
| Unknown | Predicting Obesity Consequences Using Body Measure and Urine Metabolomics NCT04989062 | Chang Gung Memorial Hospital | — |
| Unknown | Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease NCT06176079 | Michael Ohliger, MD PhD | — |
| Terminated | Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modificatio NCT04440540 | Chinese University of Hong Kong | N/A |
| Terminated | Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alco NCT04147195 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Effect of Molecular Hydrogen in Patients With NAFLD NCT05325398 | Comenius University | N/A |
| Enrolling By Invitation | Cognitive Assessment and Brain Function Evaluation in Patients With Non-alcoholic Fatty Liver Disease NCT05563259 | Yan Bi | — |
| Completed | Multi-Parametric MRI Assessment of the Liver in Diabetic Volunteers (Partners Registry) NCT04336800 | Perspectum | — |
| Active Not Recruiting | MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH) NCT04227782 | University of Oxford | — |
| Terminated | A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Di NCT04237116 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Endoscopic Gastric Plication Using the POSE2.0 Technique for Management of Fatty Liver Disease NCT05611567 | Emirates Health Services (EHS) | N/A |
| Completed | Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (P NCT04198805 | Naga P. Chalasani | Phase 2 |
| Active Not Recruiting | Characteristics of NAFLD Among Type 2 Diabetes Patients NCT04999124 | Ziekenhuis Oost-Limburg | N/A |
| Unknown | Sulforaphane Supplementation Study NCT04364360 | University of Oxford | N/A |
| Unknown | Mediterranean Diet Versus Paleolithic Diet for the Treatment of Non Alcohlic Fatty Liver Disease NCT04400864 | Rabin Medical Center | N/A |
| Completed | A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Diseas NCT04197479 | Madrigal Pharmaceuticals, Inc. | Phase 3 |
| Unknown | Weight Loss in Adults With Obesity Using a Combination of Low Energy Diet, Group Treatment and Intragastric Ba NCT04230655 | Region Örebro County | N/A |
| Terminated | The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance NCT04315350 | University Hospital, Gentofte, Copenhagen | N/A |
| Completed | Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis NCT04142749 | PharmaKing | Phase 3 |
| Completed | Hybrid Training and Middle Age NCT05231564 | University of Sistan and Baluchestan | N/A |
| Withdrawn | NASH-FITTER: Nonalcoholic Steatohepatitis Fitness Intervention Treatment Targeting Endothelial Dysfunction Rev NCT03864835 | Milton S. Hershey Medical Center | N/A |
| Completed | Glucagon Resistance in Patients With NAFLD NCT04042142 | University of Aarhus | N/A |
| Withdrawn | Silymarin in NAFLD NCT02973295 | University Hospital Rijeka | Phase 4 |
| Unknown | NAFLD Study: US vs Liver Biopsy NCT04101162 | University of Roma La Sapienza | N/A |
| Completed | Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome NCT04117802 | Laval University | N/A |
| Completed | Alternate Day Fasting, Exercise, and NAFLD NCT04004403 | University of Illinois at Chicago | N/A |
| Completed | Macrophage-mediated Inflammation in White Adipose Tissue and Non-alcoholic Fatty Liver Disease. NCT04059068 | Imperial College London | — |
| Unknown | The Effect of Probiotics on the Clinical Outcomes and Gut Microenvironment in Patients With Fatty Liver NCT04074889 | Universiti Kebangsaan Malaysia Medical Centre | N/A |
| Terminated | Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH NCT04048876 | Celgene | Phase 2 |
| Completed | Bariatric Surgery on NASH NCT04043585 | University Hospital, Gentofte, Copenhagen | — |
| Completed | Super HEROES: Searching How the Extract Rebaudioside Occludes Excess Steatosis NCT03985020 | Children's Hospital Los Angeles | N/A |
| Recruiting | Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD NCT03884075 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Completed | The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules NCT05042245 | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Phase 4 |
| Unknown | Lifestyle Interventions for the Treatment of Non-alcoholic Fatty Liver Disease in Overweight and Obese Adults NCT03972631 | First Affiliated Hospital of Zhejiang University | N/A |
| Completed | Integrated Approaches for Identifying Molecular Targets in Liver Disease NCT03915002 | University of Pittsburgh | — |
| Terminated | NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation NCT03866421 | Rigshospitalet, Denmark | — |
| Completed | Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis NCT05357352 | Methodist Health System | — |
| Unknown | Investigation on the Role of Gut-liver Axis for Non-alcoholic Steatohepatitis Through Bariatric Surgery NCT04501042 | National Taiwan University Hospital | — |
| Completed | NAFLD Among Patients With Type 2 Diabetes and CKD NCT03826381 | Rigshospitalet, Denmark | — |
| Completed | Exercise Study in Subjects With NAFLD NCT03995056 | University of Eastern Finland | N/A |
| Unknown | NASH and Coronary Disease NCT03819283 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases NCT03910361 | Dong-A ST Co., Ltd. | Phase 4 |
| Completed | Biological Adaptations of Strength Training. NCT04098484 | Democritus University of Thrace | N/A |
| Recruiting | Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention NCT03875625 | Chinese University of Hong Kong | N/A |
| Unknown | Effect of Modified Time-restricted Feeding in Preventing Progression of Non-Alcoholic Fatty Liver Disease (NAF NCT03848390 | The University of Texas Health Science Center, Houston | N/A |
| Unknown | Measuring Fatty Liver With Ultrasound and MRS in Children With Overweight or Obesity NCT03787108 | Maastricht University Medical Center | — |
| Completed | Structured Mobile Technology Based Lifestyle Program vs Usual Care for Patients With Non-alcoholic Fatty Liver NCT03839082 | University of Michigan | N/A |
| Recruiting | Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease NCT04141592 | Queen Mary University of London | — |
| Completed | Role of Obeticholic Acid in the Patients of NAFLD With Raised ALT NCT03836937 | Sir Salimullah Medical College Mitford Hospital | N/A |
| Completed | The Effect of Curcumin on Liver Fat Content in Obese Subjects NCT03864783 | Steno Diabetes Center Copenhagen | N/A |
| Withdrawn | Evaluating the Efficacy of CPAP Therapy for the Treatment of Fatty Liver NCT01849081 | Massachusetts General Hospital | N/A |
| Unknown | Efficacy of Silymarin in Patients With Non-alcoholic Fatty Liver Disease - The SILIVER Trial NCT03749070 | Camila Ribeiro de Avelar | N/A |
| Unknown | Hepaxa Management of Non-alcoholic Fatty Liver Disease NCT03801577 | BASF AS | N/A |
| Completed | Liver Health and Metabolic Function in People With Obesity NCT03701828 | Washington University School of Medicine | N/A |
| Unknown | Hepatic Histology and Metabolism Following Total Pancreatectomy and Pancreaticoduodenectomy NCT03864744 | Steno Diabetes Center Copenhagen | — |
| Recruiting | Cold-induced Brown Fat Activation and Hepatic Steatosis NCT03811236 | Medical University of Vienna | N/A |
| Completed | Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascu NCT03375788 | Massachusetts General Hospital | Phase 2 |
| Completed | Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients NCT03850886 | Ain Shams University | Phase 2 |
| Recruiting | Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients NCT04785937 | Azienda USL Reggio Emilia - IRCCS | N/A |
| Completed | 12-Month Once-a-week HIIT Improves Body Adiposity and Liver Fat NCT03912272 | The University of Hong Kong | N/A |
| Completed | Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease NCT03590626 | Medanta, The Medicity, India | N/A |
| Recruiting | Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI NCT05046483 | German Diabetes Center | — |
| Completed | Antidiabetic Drugs for Steatotic Liver Disease NCT03646292 | Yonsei University | Phase 4 |
| Completed | Functional Roll for Non-alcoholic Fatty Liver Disease NCT04520724 | Pomeranian Medical University Szczecin | N/A |
| Completed | Early Detection of Advanced Fatty Liver Disease NCT03608748 | HaEmek Medical Center, Israel | — |
| Completed | Diabetes, Exercise and Liver Fat (DELIVER) NCT04004273 | James King | N/A |
| Completed | Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD) NCT04049396 | Lida Nejati | N/A |
| Completed | Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment NCT03681457 | Novartis Pharmaceuticals | Phase 1 |
| Completed | Hydrogen-rich Water for Non-alchoholic Fatty Liver Disease NCT03625362 | University of Novi Sad, Faculty of Sport and Physical Education | N/A |
| Unknown | Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD) NCT03613480 | University Hospital of Patras | N/A |
| Unknown | Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease NCT03635541 | Beijing Friendship Hospital | — |
| Recruiting | Prognostic Significance of Fatty Liver Disease in Bariatric Patients NCT03535142 | Esbjerg Hospital - University Hospital of Southern Denmark | N/A |
| Completed | Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnose NCT03796975 | Xijing Hospital | Phase 4 |
| Completed | 2-Week Study In People With Nonalcoholic Fatty Liver Disease NCT03513588 | Pfizer | Phase 1 |
| Completed | Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18) NCT05946148 | National and Kapodistrian University of Athens | — |
| Unknown | Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity NCT03492879 | Prof. Ziv Ben-Ari MD | N/A |
| Terminated | Effects of Probiotic on Inflammation and Microbiota in Patients With NASH NCT03511365 | Northwell Health | Phase 1 / Phase 2 |
| Completed | Technical Validation of MR Biomarkers of Obesity-Associated NAFLD NCT03674528 | University of Wisconsin, Madison | — |
| Unknown | Plant Sterols and Plant Stanols and Liver Inflammation NCT03627819 | Maastricht University Medical Center | N/A |
| Completed | Hepatic Metabolic Changes in Response to Glucagon Infusion NCT03526445 | Steno Diabetes Center Copenhagen | N/A |
| Unknown | Assessment of Renal Changes in Patients With Non Alcoholic Fatty Liver Disease NCT03487068 | Assiut University | N/A |
| Unknown | Multicenter, Randomized, Controlled and Double-blind Study of Efficacy and Safety of Endoscopic Gastric Tubuli NCT03426111 | Puerta de Hierro University Hospital | N/A |
| Completed | Effects of Carnitine Supplementation on Liver and Muscle NCT03439917 | University of Nottingham | N/A |
| Terminated | Gemcabene for the Treatment of Pediatric NAFLD NCT03436420 | Emory University | Phase 2 |